FIELD: medicine.
SUBSTANCE: therapy involves introduction of sonicated human DNA combined with nonhistone protein to the patient with the length of human DNA fragments making 200-6000 pairs of bases, and the ratio of sonicated human DNA/nonhistone protein being 1/0.8. The complex is administered in a dose to ensure the blood concentration of sonicated human DNA 25 ng/ml - 1000 ng/ml.
EFFECT: application of the invention implies oncotherapy ensured by substitution of replacement oncolocus by a DNA fragment with nonmutant allele to form a nucleotide stable complex.
2 cl, 4 tbl, 11 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD OF DETECTING STEM CANCER CELLS | 2013 |
|
RU2530170C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2006 |
|
RU2313349C2 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
Authors
Dates
2010-04-27—Published
2008-08-28—Filed